Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current Understanding and Management of Intraductal Carcinoma of the Prostate.

Current oncology reports - 16 Jul 2021

Considine Bryden, Adeniran Adebowale, Hurwitz Michael E

Abstract excerpt

PURPOSE OF REVIEW: This review will discuss current understanding and management approaches of Intraductal carcinoma of the prostate (IDC-P). IDC-P is a histological finding characterized by neoplastic cells that expand but do not invade prostate ducts. RECENT FINDINGS: The presence of IDC-P on a prostate biopsy is almost always associated with an invasive disease component and is independently associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ductal
Share to DNA Mismatch Repair
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microsatellite Instability

Share to Mutation

Share to Neoplasm Grading

Share to Prostatic Neoplasms

Share to Signal Transduction

Source

Identifiers

PMID: 34272624
DOI: 10.1007/s11912-021-01090-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current Understanding and Management of Intraductal Carcinoma of the Prostate.PMID 34272624Read ↗

Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate.Semantic proximity Read ↗

Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?Semantic proximity Read ↗

Unfavorable Pathology, Tissue Biomarkers and Genomic Tests With Clinical Implications in Prostate Cancer Management.Semantic proximity Read ↗

Contemporary Management of Prostate CancerSemantic proximity Read ↗

Intraductal carcinoma of the prostate in the absence of high‐grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutationsSemantic proximity Read ↗

Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the ProstateSemantic proximity Read ↗

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.Semantic proximity Read ↗

Practice guidelines for prostate cancer.Semantic proximity Read ↗

Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with 68Ga-PSMA, radiolabelled choline and 68Ga-DOTATATE.Semantic proximity Read ↗

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterationsSemantic proximity Read ↗

Is high-grade prostatic intraepithelial neoplasia (HGPIN) a reliable precursor for prostate carcinoma? Implications for clonal evolution and early detection strategies.Semantic proximity Read ↗

Clinical and Genomic Features of Androgen Indifferent Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.